Cannabis Operators Warn Corporate Psychedelics Repeating Same Mistakes

The Warning From the Cannabis Trenches

Legacy cannabis operators say psychedelic licensing frameworks in Oregon, Colorado, and California mirror the vertical-integration mandates and capital barriers that collapsed small-batch cannabis businesses. The pattern shows up in Oregon's psilocybin rules, which require facilitators to operate standalone centers with liability insurance few independents can afford. Colorado's pending psychedelic-therapy regulations favor clinic chains over individual practitioners.

Maya Ortiz closed her Oakland microbusiness in 2023 after California's track-and-trace system priced her out. Now she consults for psychedelic startups. She's seeing the same lobbyists. "The people writing these rules didn't learn from cannabis," Ortiz said in an interview Thursday. "They're copying it."

Vertical Integration as Market-Capture Tool

Vertical integration — the requirement that one license holder control cultivation, processing, and retail — became the primary mechanism for corporate consolidation in cannabis markets. Massachusetts, New York, and Illinois all adopted vertical mandates that required $2 million to $10 million in upfront capital. That effectively barred craft operators.

Psychedelic frameworks are following suit. Oregon's Measure 109 allows psilocybin service centers to vertically integrate cultivation and administration. Colorado's Natural Medicine Advisory Board has discussed similar structures for its 2026 rollout.

The Licensing-Fee Ladder

Application fees in mature cannabis states ranged from $5,000 in Oklahoma to $250,000 in Illinois, with the highest fees correlating to the lowest rate of minority ownership. Psychedelic licensing is starting at the top of that ladder. Oregon's psilocybin facilitator license costs $10,000 for a two-year term, plus $5,000 for each service-center location.

Colorado's draft rules propose a tiered system with fees up to $15,000 for healing centers. The structure mirrors Illinois' cannabis model, which produced a market where 75% of licenses are held by multi-state operators.

Corporate Lobbying Shapes the Rules

Multi-state psychedelic operators including Numinus Wellness, Compass Pathways, and Cybin have hired the same lobbying firms that wrote vertical-integration language into state cannabis laws. Numinus retained Denver-based Vicente Sederberg, the firm that authored Colorado's cannabis regulatory framework in 2013.

The regulatory architecture is being built by the same people who designed cannabis markets to favor capital over craft.

Compass Pathways holds patents on synthetic psilocybin formulations. It's lobbied Oregon and California regulators to require standardized dosing protocols that would exclude naturally cultivated mushrooms.

The Social-Equity Mirage

Social-equity programs in cannabis promised priority licensing for communities harmed by the War on Drugs but delivered ownership rates below 5% in every state that tracked demographics. New York's cannabis program reserved 50% of licenses for equity applicants. It failed to fund technical assistance or low-cost capital. Most equity winners couldn't open.

Psychedelic equity programs are copying the structure without the funding. Colorado's Natural Medicine Equity Grant Program allocated $2 million for training but zero dollars for startup capital or rent subsidies.

What Craft Operators Lost

Between 2018 and 2024, California issued 7,200 cannabis cultivation licenses but saw 3,100 operators exit the market, with closure rates highest among farms under 10,000 square feet. The exodus was driven by a combination of 280E tax burdens, track-and-trace costs, and wholesale price collapse as corporate farms flooded supply.

For context on how corporate consolidation reshaped cannabis markets, see the CannIntel topic hub on cannabis industry corporatization. Many former cultivators now operate in the legacy market, where they face lower overhead and no compliance costs.

The Path Psychedelics Could Take

Advocates are pushing Oregon and Colorado to adopt true microbusiness structures with sub-$1,000 licensing fees, exemptions from vertical-integration mandates, and dedicated capital pools for equity operators. The Oregon Psilocybin Advisory Board will vote on microbusiness amendments in August 2026.

Without structural changes, psychedelic markets will likely mirror cannabis: consolidated ownership, collapsed wholesale prices, and a two-tier system where craft operators return to the underground. The next six months of rulemaking will determine which path the industry takes.